LSP Bibliography

1.
Kader T, Chen YA, Hug CB, Lin JR, Muhlich JL, Coy S, Jung E, Schwartz LE, Fazio T, Chiu C, Ryall ST, Drescher CW, Sorger PK, Drapkin R, Santagata S. Spatial Integration of Protein and Chromosomal States Reveals Early Copy-Number Changes and Genotype-Associated Immune Neighborhoods in Serous Ovarian Cancer Evolution. Cancer Discov. 2026 Sept 1;16(9):1750–1764. PMCID: PMC13530990
1.
Yue S, Guo Z, Pan C, Jing XA, Tao L, Nguyen T, Tang J, Chan Y, Contreras-Trujillo H, Jiang D, Yan X, Xiang H, Liu X, Bloom C, Ediriwickrema A, Koschade S, Wang X, Wang Z, Shu N, Shi Y, McKim DB, Lu R, Majeti R, Zhang C, Ying QL. Expansion and CAR engineering of granulocyte-monocyte progenitors for cellular immunotherapy. Cell. 2026 Aug 20;189(17):5378-5395.e11. PMID: 42320470
1.
Rudra Gupta T, Polley MYC, Redd R, Lee EQ, Arrillaga-Romany I, Gilbert MR, Tan Y, Touat M, Drappatz J, Welch MR, Galanis E, Ahluwalia MS, Colman H, Nabors LB, Hepel J, Elinzano H, Schiff D, Chukwueke UN, Beroukhim R, Nayak L, McFaline-Figueroa JR, Batchelor TT, Kaley TJ, Lu-Emerson C, Mellinghoff IK, Bi WL, Arnaout O, Peruzzi PP, Haas-Kogan D, Tanguturi S, Aizer A, Doherty L, Santagata S, Meredith DM, Chiocca EA, Reardon DA, Ligon KL, Weller M, Mehta MP, Wen PY, Trippa L, Rahman R. Treatment Effect Reanalysis of the Randomized Individual Screening Trial of Innovative Glioblastoma Therapy in Newly Diagnosed Glioblastoma With External Control Data. J Clin Oncol. 2026 July 20;44(21):2048–2058. PMCID: PMC13418303
1.
Ma Y, Tagore M, Hunter MV, Huang TH, Montal E, Weiss JM, Shi Y, Vallius T, Sorger PK, White RM. Restraint of melanoma progression by cells in the local skin environment. Elife. 2026 June 30;13:RP101974. PMCID: PMC13318302
1.
Zamora AD, Pai SV, Mears KS, Rossine F, Owen SV, Baym M. SOS-mediated prophage induction constrains resistance evolution to DNA-damaging antibiotics [Internet]. bioRxiv; 2026 [cited 2026 July 17]. Available from: http://biorxiv.org/lookup/doi/10.64898/2026.06.23.733845
1.
Gonzalez Castro LN, Wu YC, Lin JR, Santiago-Ribeiro MJ, Laurenge A, Carpentier A, Coy S, Lin NU, Mokhtari K, Ligon KL, Touat M, Santagata S. Clinical responses to trastuzumab deruxtecan in molecularly defined ependymoma. NPJ Precis Oncol. 2026 June 20; PMID: 42321415
1.
Xu R, Wu G, Rice S, Booker M, Weekes J, Bell H, Gao Y, Nirmal AJ, Liu H, Ciantra Z, Luo Q, Fortune A, Whalen K, Guanci T, Wan Y, Louissaint A, Nordberg JJ, Lin JR, Hemann M, Manalis SR, Armand P, Smith E, Jacobson CA, Tolstorukov M, Murakami MA, Sorger PK, Weinstock DM, Song L, Lane AA. Live-cell Pick-Seq (LiP-Seq): Interrogating ultra-rare mantle cell lymphoma persistent cells after CART19 therapy. Blood Adv. 2026 June 9;10(11):3845–3855. PMCID: PMC13234471
1.
Ogbonna EC, Talemi SR, Maliga Z, Zhao Z, Yapp C, Pant SM, Lu YD, Muhlich J, Gagné A, Martinot AJ, Coy S, Santagata S, Shih AR, Solomon IH, Naidoo T, Aldridge BB, Steyn AJC, Sorger PK. Modeling development of tertiary lymphoid structures in pulmonary tuberculosis by 3D profiling and trajectory analysis [Internet]. bioRxiv; 2026 [cited 2026 June 8]. Available from: http://biorxiv.org/lookup/doi/10.64898/2026.06.02.725201
1.
Li B, Mitchison TJ. Rebinding drives cellular retention of small-molecule drugs with abundant targets. Proc Natl Acad Sci U S A. 2026 May 26;123(21):e2531949123. PMCID: PMC13213988
1.
Wong AYH, Lu YD, Zhao Z, Zhou F, Park H, Maliga Z, Anang YNA, Coy S, Danuser G, Santagata S, Yapp C, Sorger PK. Volumetric Cyclic Immunofluorescence for 3D Spatial Profiling of Immune Structures in Human FFPE Tissue [Internet]. bioRxiv; 2026 [cited 2026 May 26]. Available from: http://biorxiv.org/lookup/doi/10.64898/2026.05.17.725158
1.
Petrova V, Mills CE, Hug C, Cetinkaya-Fisgin A, Splaine J, Fouladzadeh S, Hakim S, Powell R, Zhen S, Chung M, Bradshaw GA, Deng T, Singec I, Wang Q, Kawaguchi R, Jonnagaddala H, Barrett LB, Smith JA, Kalocsay M, Gyori BM, Hoke A, Sorger PK, Woolf CJ. A human iPSC-derived sensory neuron platform for high-throughput discovery of neuroprotectants against chemotherapy-induced peripheral neuropathy. Cell Rep Med. 2026 May 19;7(5):102787. PMCID: PMC13198234
1.
Shi Y, Savchenko A, Brase JC, Reardon B, Ricker CA, Park J, Tarantino G, Manos MP, Huang AY, Van Allen EM, Garraway LA, Flaherty KT, Liu D. Genomic, Clinical, and Spatial Predictors of Durable Response to BRAF/MEK Inhibition in BRAF -Mutant Melanoma [Internet]. bioRxiv; 2026 [cited 2026 July 17]. Available from: http://biorxiv.org/lookup/doi/10.64898/2026.05.09.721157 PMCID: PMC13192995
1.
Cheng X, Zhang Y, Qian C, Holdridge E, Ananda G, Jiang T, Ni J, Xie S, Gu H, Ji R, Ivanova EV, Nucci MR, Wang Z, Chen K, Kochupurakkal B, Freeman GJ, Shapiro GI, Liu J, Konstantinopoulos PA, Matulonis U, Zhao JJ. Targeting FGFR signaling overcomes therapeutic resistance and immune evasion in oncogenic PIK3CA-driven serous-like endometrial cancer. Nat Commun. 2026 May 4;17(1):5994. PMCID: PMC13347040
1.
Guo X, Moynihan ZA, Driver J, Patel RV, Bhave VM, Maury EA, Knelson EH, Guo H, Lin JR, Coy SM, Wang A, Gupta S, Hoffman SE, Dunn IF, Dunn GP, Petti A, Choi BD, Choudhury A, Raleigh DR, Wei K, Reardon DA, Barbie D, Lederer JA, Santagata S, Bi WL. Meningioma microenvironment harbors a rich immune landscape that evolves with biological state. Neuro Oncol. 2026 May 1;28(5):1193–1208. PMCID: PMC13186497
1.
Hess JM, Dzeng RK, Ilieş I, Schapiro D, Iskra JJ, Mirgh D, Nam J, Seeley EH, Verrill DE, Abdelmoula WM, Regan MS, Theocharidis G, Wu CL, Veves A, Agar NYR, Sluder AE, Poznansky MC, Sîrbulescu RF, Reeves PM. MIAAIM: Multi-omics image integration with dimensional reduction for tissue state mapping. PLoS Comput Biol. 2026 May;22(5):e1014274. PMCID: PMC13225665
1.
Cassandras M, Sanchez X, Hsu L, Huang Y, Getzler AJ, Ganguly D, Baldominos P, Codinachs I, Chuong J, Martin EE, Smith BE, Marina E, Spasic M, Qin X, Parsons HA, Mayer EL, Sarosiek KA, Dougan SK, Mittendorf EA, McAllister SS, Hsu YC, Agudo J. A glucocorticoid-FAS axis controls immune evasion during metastatic seeding. Nature. 2026 May;653(8114):567–575. PMID: 41781620
1.
Gagné A, Lin JR. Moving Beyond Morphology to Multiplexed Molecular Imaging as the Next Frontier in Diagnostic Pathology. Am J Pathol. 2026 Apr 30;S0002-9440(26)00123–9. PMID: 42069143
1.
Tan SZK, Puig-Barbe A, Goutte-Gattat D, Eastwood C, Aevermann B, Avola A, Balhoff JP, Bayindir IU, Belfiore J, Caron AR, Fischer DS, George N, Gyori BM, Haendel MA, Hoyt CT, Kir H, Lubiana T, Matentzoglu N, Overton JA, Peng B, Peters B, Quardokus EM, Ray PL, Roncaglia P, Rivera AD, Stefancsik R, Teh WK, Toro S, Vasilevsky N, Xu C, Zhang Y, Scheuermann RH, Mungall CJ, Diehl AD, Osumi-Sutherland D. The Cell Ontology in the age of single-cell omics. Sci Data. 2026 Apr 24;13(1):946. PMCID: PMC13315338
1.
Mills CE, Hug C, Sajeevan KA, Clark N, Victor C, Chung M, Rawat S, D’Erasmo H, Moraes MP, Aldridge B, Albers MW, Chowdhury R, Gyori BM, Sorger PK. Polypharmacology is an enduring and nearly universal property of kinase inhibitors [Internet]. bioRxiv; 2026 [cited 2026 July 17]. Available from: http://biorxiv.org/lookup/doi/10.64898/2026.03.17.711623
1.
König LE, Rodriguez S, Hug C, Daneshvari S, Chung A, Appleman M, Tsai M, Bradshaw GA, Sahin A, Song Y, Zhou G, Eisert RJ, Piccioni F, Marques C, Powley S, Yarmolinsky J, Wainger BJ, Das S, Kalocsay M, Dehghan A, Tzoulaki I, Sokolov A, Sorger P, Root DE, Albers MW. TYK2 mediates neuroinflammation in Alzheimer’s disease brains with TDP-43 pathology. Nat Commun. 2026 Mar 14;17(1):3967. PMCID: PMC13133158
1.
Perez-Villatoro F, Shabanova A, van Wagensveld L, Junquera A, Niemiec I, Hincapié-Otero MM, Kang Z, Falco MM, Birgin K, Wolf S, Anttila E, Anandagoda G, Casado J, Marcus E, Gaillard D, Kahelin E, Chamchougia F, Salko M, Shah S, Russo S, Chiaro J, Grönholm M, Ndika J, Kari OK, iCAN iCAN, Sonke GS, Van de Vijver KK, Fpm Kruitwagen R, van der Aa M, Virtanen A, Cerullo V, Vähärautio A, Sorger PK, Horlings HM, Farkkila A. Single-cell spatial atlas of high-grade serous ovarian cancer uncovers MHC class II as a key predictor of spatial tumor ecosystems and clinical outcomes. Cancer Discov. 2026 Feb 9; PMID: 41661089
1.
Zimmerman MP, Huang AY, Cox EK, Al Abosy R, Chong WL, Bastian AG, Vietor K, Choutri Y, Collier J, Zhabotynsky V, Wang H, Fung M, Weiss SA, Robitschek EJ, Lin JR, Vallius T, Pant SM, Sorger PK, Hugo W, Sen DR, Haining WN, Sharpe AH, Miller BC. Harnessing Inflammatory Monocytes to Overcome Resistance to Anti-PD-1 Immunotherapy [Internet]. Immunology; 2026 [cited 2026 July 17]. Available from: http://biorxiv.org/lookup/doi/10.64898/2026.02.05.704029
1.
Brastianos PK, Dooley K, Geyer S, Gerstner ER, Kaufmann TJ, Iafrate AJ, Martinez-Lage M, Milhem M, Welch MR, Kaley TJ, Drappatz J, Chan A, Kumthekar P, Matsuoka CK, Strowd RE, Cohen AL, Jaeckle K, Robell L, Magge RS, Nam JY, Blondin N, Shaikh N, Rabinowitz I, Thomas AA, Piccioni DE, Brown P, Kaluziak S, Codd E, Cahill DP, Santagata S, Barker FG, Galanis E. Abemaciclib in meningiomas with somatic NF2 or CDK pathway alterations: the phase 2 Alliance A071401 trial. Nat Med. 2026 Feb;32(2):717–724. PMCID: PMC12920099
1.
Pimenta EM, Garza AE, Camp SY, Park J, Hoffman SE, Valderrábano L, Fu J, Bi K, Carson MT, Karam J, Titchen BM, Medjahed S, Khandekar MJ, Shannon E, Kang YJ, Coy S, Lin JR, Nag A, Thorner AR, Gibson WJ, Santagata S, Raut CP, Hornick JL, Merriam P, Solimini NL, George S, Demetri GD, Van Allen EM. Epigenetic dysregulation of metabolic programs mediates liposarcoma cell plasticity. Sci Transl Med. 2026 Jan 21;18(833):eadw4689. PMCID: PMC13062979
1.
Darnell AM, Chidley C, Paradise V, Cui DS, Davidsen K, Lincoln SC, Abbott KL, Elbashir R, Vander Heiden CP, Sorger PK, Sullivan LB, Davis JH, Vander Heiden MG. Ribosome-associated quality control of aberrant protein production during amino acid limitation [Internet]. bioRxiv; 2026 [cited 2026 Jan 20]. Available from: http://biorxiv.org/lookup/doi/10.64898/2026.01.14.699605
1.
Weems AD, Islam MT, Borges H, Yapp C, Perez-Castro L, Nogueira P, Lin J, Maliga Z, Lewis AJ, Kutter C, Mannino M, Vallius T, Santagata S, Sorger PK, Conacci-Sorrell M, Dean KM, Danuser GM. In vivo evidence for bleb-induced survival signaling in metastatic melanoma [Internet]. Cancer Biology; 2026 [cited 2026 Jan 6]. Available from: http://biorxiv.org/lookup/doi/10.64898/2026.01.05.697601
1.
Ribas GT, Cunha AF, Avila JP, Giarraputo A, Morena L, Lima K, Gassen RB, Chen JY, Lin JR, Santagata S, Avillach CT, Ryback BA, Lindner MS, Bercovici S, Rosales IA, Kawai T, Nakaya HI, Colvin RB, Borges TJ, Riella LV. Immune profiling in a living human recipient of a gene-edited pig kidney. Nat Med. 2026 Jan;32(1):270–280. PMCID: PMC12823403
1.
Burn TN, Schröder J, Gandolfo LC, Osman M, Wainwright EN, Lam EYN, McDonald KM, Evans RB, Li S, Rawlinson D, Dryburgh L, Zaid A, Maliga Z, Schienstock D, Meiser P, Lee HJ, Lai H, Moreira ML, Zareie P, Lee LHY, Huq L, Christo SN, Seow JJW, Ching KA, Guillaume SM, Knezevic K, Park SL, Evrard M, Waithman J, Gebhardt T, Mueller SN, Riddiough GE, Perini MV, Tsao SCH, Speed TP, Sorger PK, Loi S, Carbone FR, Gras S, Fisher TS, Baaten BJ, Dawson MA, Mackay LK. Antigen reactivity defines tissue-resident memory and exhausted T cells in tumors. Nat Immunol. 2026 Jan;27(1):98–109. PMCID: PMC12764432
1.
Warchol S, Guo G, Knitte J, Freeman D, Shalla U, Muhlich JL, Sorger PK, Pfister H. SEAL: Spatially-resolved Embedding Analysis with Linked Imaging Data. IEEE Trans Vis Comput Graph. 2026 Jan;32(1):484–494. PMCID: PMC13130870
1.
Rapisuwon S, Slingluff CL, Wargo JA, Sullivan RJ, Izar B, Lin JR, Mauldin IS, Olson WC, Tran CA, Schwartzman GH, Gibney GT, Al-Refaie W, Atkins MB. Effects of Vemurafenib ± Cobimetinib on Intratumoral and Host Immunity in Patients With BRAFV600 Mutant Melanoma: Implications for Combination With Immunotherapy. Cancer Med. 2026 Jan;15(1):e71526. PMCID: PMC12789045
1.
Rossine F, Sanchez C, Eaton D, Paulsson J, Baym M. Intracellular competition shapes plasmid population dynamics. Science. New York, N.Y.; 2025 Dec 18;390(6779):eadx0665. PMCID: PMC13316098
1.
Shi Y, Maliga Z, Vallius T, Pant SM, Pelletier R, Kobs B, Solanky P, He Y, Van Allen E, Santagata S, Ott P, Lian CG, Buchbinder E, Liu D, Sorger PK. Mechanisms of tumor persistence in metastatic melanoma following successful immunotherapy [Internet]. bioRxiv; 2025 [cited 2025 Dec 16]. Available from: http://biorxiv.org/lookup/doi/10.64898/2025.12.11.692633
1.
Deng X, Bradshaw GA, Kalocsay M, Mitchison T. Tubulin regulates stability and localization of STMN2 by binding preferentially to its soluble form. J Cell Biol. 2025 Dec 1;224(12):e202502192. PMCID: PMC12803766
1.
Ludin A, Stirtz GL, Tal A, Nirmal AJ, Pfaff KL, Manos M, Besson N, Eskndir N, Porter B, Jones SM, Faulkner HM, Gong Q, Liu S, Barrera I, Wu L, Pessoa Rodrigues C, Sahu A, Jerison E, Alessi JV, Ricciuti B, Richardson DS, Weiss JD, Moreau HM, Stanhope ME, Afeyan AB, Sefton J, McCall WD, Formato E, Yang S, Zhou Y, Hoytema van Konijnenburg DP, Cole HL, Cordova M, Deng L, Rajadhyaksha M, Quake SR, Awad MM, Chen F, Wucherpfennig KW, Sorger PK, Hodi FS, Rodig SJ, Murphy GF, Zon LI. CRATER tumor niches facilitate CD8+ T cell engagement and correspond with immunotherapy success. Cell. 2025 Nov 26;188(24):6720-6736.e26. PMCID: PMC12604482
1.
Girnius N, Vallius T, Chen W, Launonen IM, Palomino-Echeverria S, Lin JR, Mills CE, Kauppila S, Kronqvist P, Ellonen A, Perala M, Withnell E, Chen YA, Secrier M, Santagata S, Sorger PK, Farkkila A. Integrative single-cell and spatial mapping of oxidative stress response uncovers GCLC+ mesenchymal tumor cell state linked with favorable outcomes in triple negative breast cancer [Internet]. bioRxiv; 2025 [cited 2026 Jan 26]. Available from: http://biorxiv.org/lookup/doi/10.1101/2025.11.06.686771
1.
Stopka SA, Bodineau C, Baquer G, Lin JR, Hossain MA, Martinez CJ, Regan MS, Ruiz D, Fletcher SM, Pourquié O, Lutsenko S, Payne CN, Agar JN, Mazitschek R, McDannold NJ, Sorger PK, Santagata S, Agar NYR. Spatial Profiling of Elements through Matrix-Assisted Laser Desorption Ionization Mass Spectrometry Imaging. Anal Chem. 2025 Nov 7; PMID: 41201007
1.
Li D, Wan G, Wu X, Wu X, Chen X, He Y, Chen Z, Sorger PK, Zhao C. Multi-Modal Foundation Models for Computational Pathology: A Survey. Transact Mach Learn Res. 2025 Nov;2025:5715. PMCID: PMC13081565
1.
Zhou FY, Marin Z, Yapp C, Zou Q, Nanes BA, Daetwyler S, Jamieson AR, Islam MT, Jenkins E, Gihana GM, Lin J, Borges HM, Chang BJ, Weems A, Morrison SJ, Sorger PK, Fiolka R, Dean KM, Danuser G. Universal consensus 3D segmentation of cells from 2D segmented stacks. Nat Methods. 2025 Nov;22(11):2386–2399. PMCID: PMC12615268
1.
Williams JB, Pant SM, Kley AL, Rajmalani BA, Yapp C, Zhang J, Rotrosen E, Sales A, Sorger PK, Kupper TS. Regulatory T cells inhibit CD8+ TRM-like cells during the early stages of tumor immune escape [Internet]. bioRxiv; 2025 [cited 2025 Oct 23]. Available from: http://biorxiv.org/lookup/doi/10.1101/2025.10.21.683143
1.
Tarantino G, Zaremba A, Vallius T, Woodnorth M, Hua Y, Pelletier R, Lopez Leon M, Shi Y, Maliga Z, Makhzami S, Aprati TJ, Karlas B, Glutsch V, Schilling B, Hassel J, Berking C, Utikal J, Meier F, Meiss F, Heinzerling L, Kahler K, Chen J, Zimmer L, Sucker A, Livingstone E, Hadaschik E, Lian C, Murphy G, Semenov YR, Boland GM, Sorger PK, Rambow F, Liu D, Schadendorf D. Multiomic profiling of a unique in-transit melanoma cohort identifies melanoma differentiation as predictor of tumor progression and therapy response [Internet]. bioRxiv; 2025 [cited 2025 Oct 3]. Available from: http://biorxiv.org/lookup/doi/10.1101/2025.10.01.679282
1.
Yapp C, Nirmal AJ, Zhou F, Wong AYH, Tefft JB, Lu YD, Shang Z, Maliga Z, Llopis PM, Murphy GF, Lian CG, Danuser G, Santagata S, Sorger PK. Highly multiplexed 3D profiling of cell states and immune niches in human tumors. Nat Methods [Internet]. 2025 Oct;22(10):2180–2193. Available from: https://www.nature.com/articles/s41592-025-02824-x PMCID: PMC12510885
1.
Cortés-Ríos J, Rodriguez-Fernandez M, Sorger PK, Fröhlich F. Dynamic modelling of cell cycle arrest through integrated single-cell and mathematical modelling approaches. PLoS Comput Biol. 2025 Oct;21(10):e1012890. PMCID: PMC12520361
1.
Jain Y, Jepson J, Chen R, Maier E, Herr BW, Puig-Barbe A, Quardokus EM, Qaurooni D, Yapp C, Ewing SL, Enninful A, Farzad N, Bueckle A, Easter QT, Matuck B, Zhu C, Monte EM, Purkerson JM, Jehrio M, Misra RS, Fan R, Ginty F, Karunamurthy A, Fan J, Campbell-Thompson M, Pryhuber GS, Byrd KM, Hickey JW, Börner K. Exploring endothelial cell environments across organs in spatially resolved omics data [Internet]. bioRxiv; 2025 [cited 2025 Nov 21]. Available from: http://biorxiv.org/lookup/doi/10.1101/2025.09.23.678129 PMCID: PMC12485928
1.
Barkai O, Zhang B, Turnes BL, Arab M, Yarmolinsky DA, Zhang Z, Barrett LB, Woolf CJ. A machine learning tool with light-based image analysis for automatic classification of 3D pain behaviors. Cell Rep Methods. 2025 Sept 15;5(9):101145. PMCID: PMC12539238
1.
Kaul A, Souque C, Holland M, Baym M. Genomic resistance in historical clinical isolates increased in frequency and mobility after the age of antibiotics. Microb Genom. 2025 Sept;11(9):001474. PMCID: PMC12401160
1.
Van Itallie E, Sonnett M, Kalocsay M, Wühr M, Peshkin L, Kirschner MW. Transitions in the proteome and phospho-proteome during Xenopus laevis development. Dev Biol. 2025 Sept;525:155–171. PMCID: PMC12255230
1.
Alessi JV, Lindsay JR, Giobbie-Hurder A, Sharma B, Felt K, Kumari P, Mazor T, Cerami E, Lotter W, Altreuter J, Weirather J, Dryg I, Hoebel K, Manos M, Adib E, Curtis JD, Ricciuti B, Di Federico A, Ghandour F, Saad E, Wang XA, Pecci F, Holovatska M, Gandhi MM, Hughes ME, O’Meara TA, Chan SJ, Pfaff K, Konstantinopoulos PA, Hodi FS, Shipp MA, Signoretti S, Choueiri T, Wei XX, Santagata S, Hanna GJ, Lin NU, Tolaney SM, Liu J, Sorger PK, Lindeman N, Sholl LM, Nowak JA, Barbie D, Awad MM, Johnson BE, Rodig SJ. Immunoprofiling at an Institutional Scale Reveals That High Numbers of Intratumoral CD8+ and PD-1+ Cells Predict Superior Patient Survival Across Major Cancer Types Independent of Major Risk Factors. JCO Precis Oncol. 2025 Sept;9:e2500240. PMCID: PMC12419029
1.
Johnson WC, Alivisatos A, Smith TC, Van N, Soni V, Wallach JB, Clark NA, Fitzgerald TA, Whiteley JJ, Tan S, Sokolov A, Ando DM, Schnappinger D, Rhee KY, Aldridge BB. Integration of multi-modal measurements identifies critical mechanisms of tuberculosis drug action. Cell Syst. 2025 Aug 20;16(8):101348. PMCID: PMC12365861
1.
Mahmoud N, Qin X, Bzeih W, Khabibullin D, Alchoueiry M, Safi S, Chami J, Han T, Salem S, Priolo C, Chakraborty AA, Sarosiek KA, Henske EP. BCL-xL dependency in chromophobe renal cell carcinoma. Cancer Gene Ther. 2025 Aug 16; PMID: 40819113
1.
Das T, Bradshaw GA, Hyer J, Masek M, Kuo YM, Bachmann-Gagescu R, Kalocsay M, Nachury MV. BBSome-Mediated Clearance of Ubiquitinated IMPG2 Defines a Constitutive Ciliary Retrieval Pathway in Photoreceptors [Internet]. bioRxiv; 2025 [cited 2025 Nov 21]. Available from: http://biorxiv.org/lookup/doi/10.1101/2025.07.29.667331 PMCID: PMC12324355